{"title":"Osteoporosis secundaria","authors":"Pamela Trejo MD , Carolina Martínez MD","doi":"10.1016/j.rmclc.2025.07.002","DOIUrl":null,"url":null,"abstract":"<div><div>Secondary osteoporosis is a condition that arises as a consequence of underlying diseases or medical treatments that affect bone metabolism, in contrast to primary osteoporosis, which is associated with age-related bone loss and the hormonal changes of menopause. Its clinical presentation differs, as it can occur in younger patients and, in some cases, be associated with more severe bone loss, increasing the prevalence of fragility fractures.</div><div>Identifying secondary causes is crucial, as it directly impacts treatment strategies and fracture risk assessment. Early recognition is essential to ensure an adequate evaluation, individualize treatment based on the underlying etiology and patient needs, and ultimately prevent fragility fractures.</div><div>This review aims to highlight when to suspect secondary osteoporosis, how to properly assess it, as well as provide tools for its clinical management.</div></div>","PeriodicalId":31544,"journal":{"name":"Revista Medica Clinica Las Condes","volume":"36 4","pages":"Pages 306-314"},"PeriodicalIF":0.4000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Medica Clinica Las Condes","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0716864025000641","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Secondary osteoporosis is a condition that arises as a consequence of underlying diseases or medical treatments that affect bone metabolism, in contrast to primary osteoporosis, which is associated with age-related bone loss and the hormonal changes of menopause. Its clinical presentation differs, as it can occur in younger patients and, in some cases, be associated with more severe bone loss, increasing the prevalence of fragility fractures.
Identifying secondary causes is crucial, as it directly impacts treatment strategies and fracture risk assessment. Early recognition is essential to ensure an adequate evaluation, individualize treatment based on the underlying etiology and patient needs, and ultimately prevent fragility fractures.
This review aims to highlight when to suspect secondary osteoporosis, how to properly assess it, as well as provide tools for its clinical management.